相关实验视频
Updated: May 5, 2026

08:15
Polymeric Microneedle Array Fabrication by Photolithography
Published on: November 17, 2015
12.1K
含有甲状腺素的纳米颗粒的微针辅助皮肤输送,使得在牛皮治疗中具有持续的抗炎作用
Hongyao Du1, Jing Yang1, Mo Li2
1Hubei Engineering Research Center for Skin Repair and Theranostics, Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China. tjhappy@126.com.
Journal of materials chemistry. B
|February 20, 2024
概括
溶解装有甲甲酸纳米颗粒的微针提供了一种治疗牛皮的新方法. 这种方法可以改善药物到皮肤的输送,提高有效性,减少副作用,从而更好地治疗牛皮.
科学领域:
- 生物材料科学 生物材料科学
- 皮肤病学 皮肤病学
- 纳米技术 纳米技术
背景情况:
- 甲托雷克萨特 (MTX) 是适度至重症牛皮的第一线治疗方法.
- 口服和注射MTX具有局限性,包括低生物可用性和全身副作用.
- 微针 (MN) 技术为改善局部药物输送到皮肤病变提供了潜力.
研究的目的:
- 开发和评估一种新的微针辅助皮肤输送系统,用于治疗牛皮.
- 为了研究含有MTX (MTX@HMSN/CS) 通过溶解MN传递的酸盐涂层中空中等性二氧化纳米颗粒用于牛皮治疗的疗效.
主要方法:
- 制造了装有MTX (MTX@HMSN/CS) 的酸盐涂层的空心中等性纳米颗粒.
- MTX@HMSN/CS被纳入溶解微针 (MN) 中,用于通过皮肤输送.
- 用MTX@HMSN/CS装载的MNs的疗效在体外使用HaCaT细胞和体内使用类似牛皮的小鼠模型进行了评估.
主要成果:
- 装有MTX@HMSN/CS的MNs成功地穿透了变厚的牛皮皮,并有效地输送药物.
- 持续从HMSN/CS释放MTX超过一周,证明了持续的抗增殖和抗炎作用.
- 与MTX@HMSN/CS装载的MNs相比,MTX@HMSN/CS装载的MNs在缓解牛皮状皮肤炎症方面表现出更高的疗效,治疗频率减少.
结论:
- 装有MTX@HMSN/CS的MNs代表了对牛皮的有前途的治疗策略.
- 这种新型的输送系统提高了药物的生物可用性,减少了副作用,并提供了方便和耐用性.
- 这种方法可以有效和安全地缓解牛皮状皮肤炎症.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
780
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
Transdermal Drug Delivery Systems
238
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
238

